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Synthesis of mucoadhesive thiol-bearing microgels
from 2-(acetylthio)ethylacrylate and 2-hydroxy-
ethylmethacrylate: novel drug delivery systems for
chemotherapeutic agents to the bladder†
M. T. Cook,a S. A. Schmidt,b E. Lee,b W. Samprasit,c P. Opanasopitc and
V. V. Khutoryanskiy*b
Thiol-bearing microgels have been synthesised from copolymerisation of 2-(acetylthio)ethylacrylate and
2-hydroxyethylmethacrylate, and subsequent deprotection using sodium thiomethoxide. The concentration
of thiol groups on these microgels could be tailored by use of diﬀerent molar ratios of the two monomers.
These thiol-bearing microgels were shown to adhere to ex vivo porcine urinary bladder, which was
correlated with their level of thiolation. By simply mixing solutions of thiol-bearing microgels and doxorubicin,
high levels of drug loading into the microgels could be achieved. Thiol-bearing microgels controlled the
release of doxorubicin in a time-dependent manner over several hours. These doxorubicin-loaded thiol-
bearing microgels could have application in the treatment of early-stage bladder cancers. The method
used represents a new ‘bottom-up’ approach for the synthesis of novel mucoadhesive microgels.
Introduction
Polymeric materials capable of adhering to mucosal surfaces have
attracted significant interest of pharmaceutical researchers for the
development of novel drug delivery systems. The mucoadhesive
properties of these materials achieve better retention of dosage
forms on mucosal surfaces, which in turn will result in increased
time for absorption and improved drug bioavailability.1,2
Many diﬀerent hydrophilic polymers have been identified
as mucoadhesive. The mucoadhesion of these polymers can be
significantly enhanced when these materials are modified to
bear specific functional groups such as thiols,3 acrylates,4 or
catechols.5 Polymers bearing thiol functional groups, termed
polymeric thiomers, have been developed and widely investi-
gated for a range of transmucosal drug delivery applications
(oral, ocular, vaginal, intravesical, etc.).6 The principal method
developed by Bernkop-Schnu¨rch et al.3 to make polymeric
thiomers involves the covalent conjugation of water-soluble
polymers with thiol-containing functional molecules such
as cysteine or thioglycolic acid. These thiomers could then be
converted into particulate formulations through various methods,
such as chemical cross-linking.7 We also have demonstrated that
the mucoadhesive thiolated nanoparticles could be synthesised
using a ‘bottom-up’ approach from polyfunctional thiol-bearing
small molecules, such as 3-mercaptopropyltrimethoxysilane that
undergoes self-condensation to form particulates,8 or by reacting
tetrakis(3-mercapto-propionate) with pentaerythritol tetraacrylate
using thiol–ene click chemistry.9
The development of thiolated polymers using polymerisation
of protected thiol-bearing monomers has recently been demon-
strated by Liras and co-workers.10 They have synthesised 2-(acetyl-
thio)ethylmethacrylate as a new monomer with a thioester group
and polymerised it using atom transfer radical polymerisation.
The thioester groups could subsequently be deprotected to form a
series of well-defined thiolated thermosensitive polymers, nano-
particles or hydrogels and multidentate ligands for functionalis-
ing CdSe quantum dots, or graphene.10–14 These materials could,
however, also have application in mucoadhesion.
One potential application of mucoadhesive dosage forms is
in delivery of chemotherapeutics to the bladder.15 The surface
of the bladder is known to possess mucins,16 of the MUC1 and
MUC3 type,17 and cancers of the bladder also express bladder-
cancer-associated mucins.18 These appear to possess cysteine-rich
domains, so may be a potential target of thiomers. Zhang et al.19
and Barthelmes et al.15 have demonstrated that thiol-bearing
particles may adhere to these membranes. Bladder cancers
typically progress from the lining of the bladder, and with time
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proliferate into the surrounding tissues. Treatment of the early
stage tumors is conducted either by cystectomy or chemotherapy,19
if surgery is not suitable for the patient. Chemotherapy to the
bladder is typically administered intravesicular, and the cathe-
ter may need to remain in the patient, or the patient may need
to not urinate for one to two hours in order to maintain the
chemotherapeutic agent in the site of administration until
absorption.20 The design of a microparticulate delivery system
which was able to adhere to themucosa and deliver chemotherapy
locally may oﬀer an alternative to this procedure.
In the present study we have synthesised a new monomer
with protected thiol-groups – 2-(acetylthio)ethylacrylate (ATEA)
and have used a surfactant-free emulsion free-radical poly-
merisation with subsequent deprotection to develop a range
of microgels with thiol-bearing surfaces, with a tunable thiol
content depending on composition. The advantage of this
approach is that free thiol groups act as chain transfer agents
during polymerisation, and without protection polymerisation
could occur from the sulfur atom. These microgels were con-
firmed to be mucoadhesive and it was found that doxorubicin,
an anticancer drug, could easily be incorporated up to doses
that are therapeutically relevant for the treatment of bladder
cancer, and released from the microgels in a time-dependent
manner. This ‘bottom-up’ method of synthesis could be considered
as a new paradigm for the development of mucoadhesive thiol-
bearing materials for drug delivery.
Experimental
Materials
2-Hydroxyethyl methacrylate (HEMA) was a gift from Vista
Optics (UK). 2-Bromoethanol, ethylene glycol dimethacrylate,
potassium thioacetate, L-cysteine hydrochloride, doxorubicin
hydrochloride, Tris-buﬀered saline, FITC-dextran (10 kDa)
and 5,50-dithiobis-(2-nitrobenzoic acid) were purchased from
Sigma-Aldrich (UK). Sodium thiomethoxide and acryloyl chloride
were purchased from Alfa Aesar (UK). Dialysis membranes
(12–14 kDa MWCO) were purchased from Visking (UK). Triethyl-
amine was dried over 3 Å molecular sieves before use. 2-Hydroxy-
ethyl methacrylate was purified by vacuum distillation, all other
reagents were used without further purification. Artificial urine
was composed of sodium chloride (105.5 mM), potassium
chloride (63.7 mM), sodium citrate dihydrate (3.2 mM), sodium
dihydrogen phosphate (3.2 mM) and sodium sulfate (17 mM).21
Porcine bladder tissues were received from PC Turner abattoir
(Farmborough, UK), taken on the day of slaughter, and dissected
to yield approximately 2  2 cm2 squares of internal mucosa,
which were frozen in cling-film and stored at 20 1C.
Synthesis of 2-(hydroxyethyl) thioacetate
A procedure was modified from Liras et al.10 2-bromoethanol
(5.6 mL, 158 mmol, 1 eq.) and potassium thioacetate (20 g,
176 mmol, 1.1 eq.) were dissolved in acetone (400 mL). The
solution was then stirred overnight at room temperature. The
solution was then filtered and concentrated in vacuo. The crude
product was then re-dissolved in dichloromethane (400 mL)
and washed with deionised water (3  40 mL). After drying over
MgSO4 and filtering, the mixture was concentrated in vacuo
once more to yield a yellow-orange liquid (11.14 g). Yield: 59%.
1H NMR (400 MHz, DMSO-d6, d): 5.16 (s, 1H, OH), 3.45 (t, 2H,
SCH2CH2), 2.92 (t, 2H, SCH2CH2), 2.34 (s, 3H, CH3).
Synthesis of 2-(acetylthio)ethyl acrylate
2-(Hydroxyethyl) thioacetate (6 g, 34 mmol) and triethylamine
(7.7 mL, 54 mmol, 1.6 eq.) were dissolved in dichloromethane
(60 mL). Acryloyl chloride (4.5 mL, 54 mmol, 1.6 eq.) was added
dropwise over the course of 1 h. The mixture was then heated to
reflux and reaction allowed to proceed overnight. After cooling,
the solution was filtered, and washed with deionised water
(12 mL). The resulting solution was dried over MgSO4 and
concentrated in vacuo. The resulting liquid was vacuum distilled
to yield a pale yellow liquid (1.9 g). Yield: 22%. 1H NMR (400 MHz,
DMSO-d6, d): 6.24 (d, 1H, HCQCHH), 6.16 (dd, 1H, HCQCHH),
5.98 (d, 1H, HCQCHH), 4.22 (t, 2H, SCH2CH2), 3.16 (t, 2H,
SCH2CH2), 2.36 (s, 3H, CH3).
Synthesis of microgels
Microgels were synthesised with 100, 80, 50, 30, 10, and 0 mol%
ATEA – the remaining monomer mass being HEMA. The mass of
each monomer used in the feed mixture for each batch of
microgels is contained in Table S1 (ESI†). The general procedure
was as follows: Deionised water (45 mL) was added to a three-
necked round-bottom flask, and bubbled with nitrogen for 20min.
Meanwhile, ammonium persulfate (15 mg) was added to water
(1 mL), and stirred. Monomers (1 g) and ethylene glycol dimetha-
crylate (100 mg, 83 mL) were then added to the degassed water,
and nitrogen bubbled for a further 5 min. The solution of
ammonium persulfate was then added, and the polymerisation
mixture heated to 70 1C. After 6 h, the cloudy solution of
microgels was allowed to cool and purified by dialysis, before
lyophilisation to yield a white solid. All products were stored at
4–8 1C under nitrogen before use.
Dynamic light scattering and f-potential measurements
The z-average hydrodynamic diameter and z potential was deter-
mined using a Nano Zetasizer at 25 1C using 100 mgmL1 samples
in water, diluted 10000 fold.
Deprotection of thiol groups
The thioester moieties found in the ATEA-containing microgels
were cleaved to yield free thiol groups. The general method was
as follows: microgels (20 mg) were dissolved in methanol (6 mL),
and degassed with nitrogen bubbling. A methanolic solution
of 0.1 M sodium thiomethoxide (1.5 mL) was then added
via syringe and reaction allowed to proceed for 30 minutes
with nitrogen bubbling at room temperature. 0.1 M HCl
solution (20 mL) was then added to quench the reaction, and
the product immediately dialysed with regular changes of the
water over 24 h. The resulting cloudy liquid was lyophilised to
yield deprotected microgels.
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Determination of thiol group content
The number of thiol groups per gram of microgels was deter-
mined using Ellman’s assay.22 Microgels (3 mg) were dissolved
in 0.5 M phosphate buﬀer at pH 8 (10 mL). L-Cysteine hydro-
chloride was used as a standard solution for the calibration
curve, so a range of cysteine solutions (200–3 mg mL1) were
also prepared in phosphate buffer. Ellman’s reagent, was then
prepared by dissolution of 5,50-dithiobis-(2-nitrobenzoic acid)
(3 mg) in phosphate buffer (10 mL). Ellman’s reagent (500 mL)
was added to an aliquot (500 mL) of each microgel and standard
solution. The solutions were then left to react for 2 h in the
dark. After incubation, the microgel samples were centrifuged
to get rid of any particulates which may lead to turbidity. Three
aliquots (200 mL) of each sample and standard were placed into
a 96-well plate, and the absorbance was measured at 420 nm
using a plate reader. The concentration of thiol groups was
calculated by comparison with the calibration curve of L-cysteine
HCl, which was linear over the range measured.
Loading of doxorubicin hydrochloride into microgels
30 mol% and 80 mol% ATEA microgels (2 mg) were suspended
in Tris buﬀer adjusted to pH 7 (1 mL). 30 mM aqueous
doxorubicin hydrochloride solution (90 mL) was then added to
the microgel suspensions. The mixtures were stirred for 16 h in
dark conditions to allow doxorubicin to enter the microgels.
The resulting suspensions were centrifuged for 8 min at 13 000
rpm. The supernatants were removed using a pipette and the
remaining pellets were gently washed with 1 mL Tris buﬀer,
leaving microgels with encapsulated doxorubicin.
Confocal microscopy of doxorubicin-loaded microgels
30 mol% ATEA microgels loaded with doxorubicin were dried
onto a glass slide. They were then examined using a Nikon A1R
confocal microscope with an excitation wavelength of 488 nm
used to induce fluorescence.
Release of doxorubicin from microgels in artificial urine
Doxorubicin-loaded microgels (1 mg) were suspended in artifi-
cial urine (1 mL). The suspended particles were then trans-
ferred to individual dialysis membranes and placed into
artificial urine (80 mL) at 37 1C. The beakers were placed in
an incubator and the temperature was maintained at 37 1C.
Aliquots (3 mL) were taken from the dialysate at regular
intervals and replaced with fresh artificial urine (3 mL). The
concentration of doxorubicin in the dialysate was determined
by spectrophotometry (Jasco V-530) at 480 nm.
Labelling of microgels with 5-(iodoacetamido)fluorescein
30% and 80% ATEA microgels (10 mg) were suspended in Tris
buﬀer (pH 7, 5 mL). 5-(Iodoacetamido)fluorescein (3.6 mg) was
added directly into the microgel suspension and the mixture was
stirred for 16 h at 4 1C. The fluorescently labelled microgels were
purified by dialysis in 1 L of deionised water, which was replaced
hourly until no fluorophore was present in the dialysate, as mea-
sured by fluorometry (Jasco FP-6200) at lex: 480 nmand lem: 520 nm.
Retention of microgels on ex vivo porcine bladder
The retention of microgels on porcine bladder was assessed
using a method developed in-house, modified from a published
procedure.23,24 Solutions of microgels or FITC-dextran (1 mg mL1)
were prepared in artificial urine. An aliquot (20 mL) was pipetted
onto a 1 1 cm2 piece of ex vivo porcine bladder mucosa, which
was then placed into a sloped channel, and artificial urine
washed over the surface using a syringe pump. At pre-defined
intervals, fluorescence images of the whole tissue were acquired
using a fluorescence stereomicroscope (Leica MZ10F) with a GFP
filter (Fig. S1, ESI†). The fluorescence images were then analysed
with ImageJ to measure the pixel intensity of the images, which
was linearly correlated with the concentration of microgels pre-
sent, as determined in preliminary experiments. A ‘blank’ value of
pixel intensity was subtracted from each measurement, using an
image of the bladder mucosa without fluorescent microgels pre-
sent. The data is presented as a percent of microgels remaining on
themucosa surface, with volume of artificial urine washed over the
surface. In order to assess whether the retention of microgels was
specific to mucosa, their retention on a control substrate of PTFE
was also measured. The retention data was analysed by two-way
analysis of variance (ANOVA) with Bonferroni post hoc test to
determine significant diﬀerences in the measurements with
elution volume. The final retention % was also compared using
one-way ANOVA with Bonferroni post hoc test.
Results and discussion
Synthesis of protected microgels
Firstly, ATEA was synthesised using a two-step method (Fig. 1a),
purified by vacuum distillation, and characterised by NMR.
This confirmed that ATEA and its precursor 2-(hydroxyethyl)
thioacetate had only small levels of impurity. The yield was 22%,
which might be improved by up-scaling, due to the diﬃculty in
distilling small volumes of liquid. A range of microgels were then
synthesised using various molar ratios of ATEA to 2-hydroxyethyl-
methacrylate, a water-soluble monomer which could improve the
colloidal stability of the resulting microgels. Polymerisation to
form microgels was simply conducted by addition of the two
monomers to an aqueous solution of cross-linker (ethylene glycol
dimethacrylate), followed by thermal initiation using ammonium
persulfate (Fig. 1b), in a surfactant-free emulsion polymerisation-
type procedure.
This method resulted in microgels of between 635 and
977 nm diameter, with a highly negative z-potential in every
case, indicating good colloidal stability (Table 1). IR spectro-
scopy (Fig. S2, ESI†) on the ATEA:HEMA copolymer microgels
indicated that they also contained both monomers, charac-
terised by the presence of ATEA’s C–S thioester stretch at
approximately 1000 cm1 and HEMA’s broad O–H stretch at
3300 cm1 in spectra of copolymer microgels. The actual ATEA
content in the microgels was estimated by 1H NMR, and it
was found that the conversion of HEMA was higher than
ATEA, possibly due to the higher stability of the methacrylate
radical.
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Deprotection of microgels
The previously-synthesised ATEA-containingmicrogels were success-
fully deprotected using sodium thiomethoxide (Fig. 1c). This
deprotection method was adopted because sodium thiometh-
oxide is chemoselective in its cleavage of thioester groups in the
presence of esters.25 The removal of the acetate protecting
group from ATEA could be seen by NMR (Fig. S3 and S4, ESI†)
and FTIR (Fig. S5, ESI†), and the number of thiol groups accessible
to solvent was quantified using Ellman’s assay (Table 1). Ellman’s
assay determined that the thiol content of ATEA-containing
microgels was dependent on the concentration of ATEA in the
particles, with maximum thiol content reached at 80 mol%
ATEA in the feed mixture. 100 mol% ATEA particles were
synthesised; however, they were not dispersible in water after
deprotection. Swelling of 50 and 80 mol% ATEA particles was
apparent after deprotection (Fig. 2), which may be a result of the
acidity of the thiol groups (pKa B 8–10),
26 relative to thioesters
(pKa B 35), leading to a greater uptake of solvent and charged
species. Transmission electron microscopy (TEM) confirmed
that microgels were formed (Fig. 2), which appeared to form
clusters during sample preparation. For further experiments in
drug loading and mucoadhesion, 30 mol% and 80 mol% ATEA
microgels were taken forward, to represent particles with a low
and high level of thiol groups on their surface, respectively.
Retention of microgels on porcine urinary bladder mucosa
In order to assess the mucoadhesive properties of these thiol-
bearing microgels, their retention on ex vivo porcine urinary
bladder was assessed (Fig. 3). Thiol-bearing 30mol% and 80mol%
ATEA microgels were labelled with the fluorescein and their
retention on urinary bladdermucosa during washing with artificial
urine determined using fluorescence stereomicroscopy. In this
case, 80 mol% ATEA was chosen as it showed the highest levels
of thiol groups on its surface, and 30 mol% ATEA was a control,
having very low levels of thiol groups. It was found that the
80 mol% ATEA microgels were retained significantly ( po 0.01,
two-way ANOVA) more on the bladder mucosa than the 30 mol%
microgels. This is most likely a result of the increased number of
thiol groups on the surface of the microgels binding to cysteine-
rich domains of mucins present on the surface of the bladder
epithelium via disulfide bridges (inset, Fig. 3). Interestingly, the
retention profile of the 80 mol% ATEA microgels plateaued after
the elution of 20 mL artificial urine. This suggests that there may
be saturation of the cysteine binding sites occurring, leading
to improved retention of those microgels which are strongly
bound by covalent attachment to these sites. The percentage of
80 mol% ATEA microgels bound at the end of the experiment
was significantly more than for 30 mol% ATEA microgels, by
Fig. 1 (a) Synthetic route to ATEA, a protected thiomonomer. (b) Poly-
merisation to form ATEA:HEMA copolymer microgels, displaying the
pendant functionalities present. (c) Deprotection of ATEA using sodium
thiomethoxide to yield thiol-bearing microgels. (i) Potassium thioacetate,
acetone, 24 h. (ii) Acryloyl chloride, triethylamine, DCM, reflux, 24 h.
(iii) Ammonium persulfate, ethylene glycol dimethacrylate, water, 70 1C,
6 h. (iv) Sodium thiomethoxide, methanol, 30 min.
Table 1 Physicochemical characteristics of protected and deprotected
microgels
ATEA concentration
(mol%)
Size
(nm) PDI z-Potential
Thiol
content
(mmol g1)
ATEA
content
(mol%)
Protected
10 977 0.280 45 N/A N.D.
30 648 0.319 38 N/A 17
50 635 0.133 36 N/A 33
80 850 0.244 40 N/A 73
Deprotected
10 659 0.723 29 21  23
30 547 0.163 30 49  24
50 828 0.116 23 143  53
80 1348 0.328 26 453  133
Fig. 2 Hydrodynamic diameter of 80 mol% ATEA microgels before (green)
and after (orange) deprotection with sodium thiomethoxide, asmeasured by
dynamic light scattering. Deprotection appears to lead to the swelling of
microgels. Inset: a TEM image of thiol-bearing microgels.
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one-way ANOVA ( p o 0.05). FITC-dextran was used as a non-
mucoadhesive control, and showed no significant diﬀerence to
the 30mol% ATEAmicrogels ( p4 0.05). The retention of 30mol%
and 80 mol% ATEA microgels on an apolar polytetrafluoroethylene
surface was also determined. It was found that the microgels were
washed from the surface after 3 mL of artificial urine was eluted,
indicating that there is some selectivity in the retention of these
particles, and that the adhesion process is not simply a result
of the rheological properties of the microgels, but likely due to
interactions between the microgels and the surface of the
mucosa. The z-potential of the microgels is comparable and
highly-negative for both microgels studied, so the adhesion
process is not likely due to poor colloidal-stability leading to
deposition. As the z-potential is similar for both systems, it is
unlikely that the retention is due to surface charge. These
results point to disulphide bridge formation as the driving
force for mucoadhesion (inset, Fig. 3). Mucoadhesives acting in
this manner have been well-reported by Bernkop-Schnu¨rch and
colleagues.3
Loading of doxorubicin hydrochloride into microgels
The highly-negative z-potential of the deprotected microgels
indicates good colloidal stability, but also gives the opportunity
for incorporation of cationic species into the particles. The
ATEA:HEMA copolymer microgels were able to take-up the
chemotherapeutic agent doxorubicin hydrochloride simply by
incubation of the drug with an aqueous dispersion of micro-
gels. The microgels were able to uptake doxorubicin with
high encapsulation eﬃciencies – 75  15%, and 86  8% for
30 mol% and 80 mol% particles, respectively (Table S2, ESI†).
The difference in encapsulation efficiency (eqn (S1), ESI†) between
the different microgel compositions was found to be statistically
insignificant ( p 4 0.05, t-test). This encapsulation efficiency
resulted in a high drug loading (eqn (S2), ESI†) of between
37 and 40% by mass. Doxorubicin hydrochloride is typically
administered to bladder cancer patients as 30–100 mL of a
1 mg mL1 solution via catheter.20 Achieving this dose of
doxorubicin is possible even after loading into ATEA:HEMA
microgels, requiring 2.5 and 2.7 mg mL1 of the doxorubicin-
loaded 30 mol% and 80 mol% ATEA microgels, respectively.
Doxorubicin is a fluorescent drug, and its presence in the
thiol-bearing microgels could be seen by confocal microscopy
(Fig. 4). Microscopy appeared to indicate that doxorubicin was
absorbed into the matrix of the microgel, rather than adsorbed
to the periphery. The microgels were B0.5 mm in diameter,
consistent with dynamic light scattering measurements.
Release of doxorubicin from microgels in vitro
In order to act on a patient, doxorubicin would have to be
released from the microgels in vivo. The release behavior of the
particles was assessed by exposure of the doxorubicin-loaded
microgels to an artificial urine solution maintained at 37 1C.
The exact volume of urine contained in the bladder is diﬃcult
to precisely replicate, due to its dynamic nature. The functional
capacity of the bladder is B300 mL before micturition,27 so
large volumes may be unrealistic in vivo. A set volume of 80 mL
was used in order to ensure that sink conditions were met for
these experiments, whilst ensuring that the functional capacity
of the bladder was not exceeded. These release experiments
(Fig. 5) indicated that there was an initial burst release of
doxorubicin from the microgels, likely attributable to loosely
bound doxorubicin on the surface, followed by a time-dependent
release over 300 min. This indicates that if administered into the
bladder, the doxorubicin load should be delivered to the patient
over several hours. The data is expressed as percentage release in
Fig. 3 Retention of thiol-bearing 30 mol% (blue circles) and 80 mol%
(yellow circles) ATEA microgels on ex vivo porcine urinary bladder. FITC-
dextran (red circles) was used as a control. The retention of 30 mol% (blue
triangles) and 80 mol% (yellow triangles) ATEA microgels on PTFE was also
examined. Data expressed as mean  standard deviation (n = 3). Inset:
schematic illustration demonstrating the mechanism by which we propose
these microgels bind to the urinary bladder’s mucosal surface, at which
point, in vivo, they would deliver doxorubicin.
Fig. 4 A confocal image of doxorubicin-loaded 30 mol% ATEA microgels.
Scale: 10 mm.
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Fig. S6 (ESI†). The diﬀerence in drug release from the two diﬀerent
particle compositions was statistically insignificant ( p 4 0.05,
two-way ANOVA). This data fit well to the Higuchi model of
drug release,28,29 with an R2 value of 0.99 in both cases (Fig. S7,
ESI†). This indicates that the drug release is consistent with
Fickian diﬀusion from an insoluble matrix.
Conclusions
A series of copolymer microgels have been designed from
HEMA and ATEA, a protected thiomonomer synthesised for
this study. These microgels were between 635 and 977 nm in
diameter, and could subsequently be deprotected to yield
particles bearing varying levels of thiol groups on their surface.
A high level of thiol groups on the surface of the particles
improved the mucoadhesion capability of the copolymer micro-
gels on porcine urinary bladder tissue. It was also found that
these microgels can be loaded with doxorubicin, with potential
for site-specific delivery to the bladder via urethral catheter.
This could lead to materials which allow micturition after the
admission of chemotherapy, without loss of the drug. This
bottom-up approach could be used in future research to yield a
new generation of mucoadhesive materials.
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